A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Trial · NCT01484496
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Period 1 | STARTED | Placebo SC | 280 | |
| Period 1 | STARTED | Belimumab 200 mg SC | 556 | |
| Period 1 | STARTED | Open-Label - Placebo SC to Belimumab 200 mg SC | 0 | |
| Period 1 | STARTED | Open-Label - Belimumab 200 SC to Belimumab 200 mg SC | 0 | |
| Period 1 | COMPLETED | Placebo SC | 214 | |
| Period 1 | COMPLETED | Belimumab 200 mg SC | 463 | |
| Period 1 | COMPLETED | Open-Label - Placebo SC to Belimumab 200 mg SC | 0 | |
| Period 1 | COMPLETED | Open-Label - Belimumab 200 SC to Belimumab 200 mg SC | 0 | |
| Period 1 | NOT COMPLETED | Placebo SC | 66 | |
| Period 1 | NOT COMPLETED | Belimumab 200 mg SC | 93 | |
| Period 1 | NOT COMPLETED | Open-Label - Placebo SC to Belimumab 200 mg SC | 0 | |
| Period 1 | NOT COMPLETED | Open-Label - Belimumab 200 SC to Belimumab 200 mg SC | 0 | |
| Period 2 | STARTED | Placebo SC | 0 | |
| Period 2 | STARTED | Belimumab 200 mg SC | 0 | |
| Period 2 | STARTED | Open-Label - Placebo SC to Belimumab 200 mg SC | 206 | |
| Period 2 | STARTED | Open-Label - Belimumab 200 SC to Belimumab 200 mg SC | 456 | |
| Period 2 | COMPLETED | Placebo SC | 0 | |
| Period 2 | COMPLETED | Belimumab 200 mg SC | 0 | |
| Period 2 | COMPLETED | Open-Label - Placebo SC to Belimumab 200 mg SC | 191 | |
| Period 2 | COMPLETED | Open-Label - Belimumab 200 SC to Belimumab 200 mg SC | 434 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01484496/flow